RxDoctor Payments Data

Tyler Southern, PA

Physician Assistant · Bermuda Run, NCNPI 1326699745

Payments from drug & device makers

$8,909in general payments, 2019–2025

Across 401 payments — averaging $22.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$767
  • MDD US Operations, LLC$762
  • UCB, Inc.$478
  • Novartis$472
  • Livanova USA, Inc.$362
  • AstraZeneca$343
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$8,80899%
  • Education$1011%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)73$767
MDD US Operations, LLC4$762
UCB, Inc.16$478
Novartis33$472
Livanova USA, Inc.3$362
AstraZeneca(2 entities)16$343
EMD Serono, Inc.10$308
Biogen15$277
Neurocrine Biosciences, Inc.11$276
Teva Pharmaceuticals USA, Inc.11$267
Eisai Inc.11$226
Jazz Pharmaceuticals Inc.8$200
TG Therapeutics, Inc.5$196
SK Life Science, Inc.7$189
Lundbeck LLC9$185
Pfizer14$181
Bristol Myers Squibb9$177
Argenx US, Inc.7$171
Mallinckrodt Hospital Products Inc.6$160
Neurelis, Inc.5$156
Lilly USA, LLC8$155
Sanofi7$152
E.r. Squibb & Sons, L.L.C.2$152
Catalyst Pharmaceuticals, Inc.7$146
Acadia Pharmaceuticals Inc5$134
Amgen6$129
Amneal Pharmaceuticals LLC6$127
Alnylam Pharmaceuticals Inc.5$125
Averitas Pharma Inc.6$118
Merz Pharmaceuticals, LLC5$116
Ipsen Biopharmaceuticals, Inc5$116
CSL Behring4$102
Tanabe Pharma America, Inc.5$101
Acorda Therapeutics, Inc4$91
Sumitomo Pharma America, Inc.6$87
ANI Pharmaceuticals, Inc.5$75
Biohaven Pharmaceutical Holding Company Ltd.4$74
Insightec,inc2$57
Otsuka America Pharmaceutical, Inc.3$53
Ultragenyx Pharmaceutical Inc.2$48
Xeris Pharmaceuticals, Inc.2$42
Mylan Specialty L.p.2$42
Upsher-smith Laboratories LLC2$40
Avanir Pharmaceuticals, Inc.2$39
Kyowa Kirin, Inc.2$37
Johnson & Johnson2$35
Takeda Pharmaceuticals U.S.A., Inc.1$33
Cala Health, Inc.2$33
Sunovion Pharmaceuticals Inc.2$30
Medtronic2$27
Axsome Therapeutics, Inc.1$26
Scilex Pharmaceuticals Inc.1$24
GE HealthCare1$23
Aprecia Pharmaceuticals, LLC1$22
Corium, LLC1$22
Avion Pharmaceuticals1$22
Nevro Corp.1$20
Hospira, Inc.1$18
Supernus Pharmaceuticals, Inc.1$18
Greenwich Biosciences, Inc.1$18

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,909 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$47,244
Medicare patients
391
Services billed
802

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine15$191,242
Kesimpta PenOfatumumab17$159,105
Plegridy PenPeginterferon Beta-1a15$124,045
IngrezzaValbenazine Tosylate12$101,612
UbrelvyUbrogepant53$91,266
Emgality PenGalcanezumab-Gnlm81$73,551
GlatopaGlatiramer Acetate22$59,136
Aimovig AutoinjectorErenumab-Aooe53$53,420
QuliptaAtogepant33$44,988
Nurtec OdtRimegepant Sulfate30$44,862
Ajovy AutoinjectorFremanezumab-Vfrm39$44,302
RytaryCarbidopa/Levodopa19$32,531
KeppraLevetiracetam13$20,341
FycompaPerampanel15$18,944
OngentysOpicapone19$12,170

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$267$191,24215 claims
AbbVieUbrelvy, Qulipta$767$136,25386 claims
Neurocrine Biosciences, Inc.Ingrezza, Ongentys$276$113,78331 claims
PfizerNurtec Odt, Dilantin$181$46,91043 claims
Amneal Pharmaceuticals LLCRytary, Mycophenolate Mofetil$127$35,00852 claims
Eisai Inc.Fycompa$226$18,94415 claims
Upsher-smith Laboratories LLCTopiramate$40$1,13889 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Bermuda Run

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →